Abivax - ADR
ABVX
Get informed when a big investor buys or sells
+ FollowMarket Cap$10.03B
Close$
$7.74
94% downside
Current Fair Value
94% downsideOvervalued by 94% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $10.03 Billion |
|---|---|
| Enterprise Value | $9.55 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.65 |
| Beta | -0.21 |
| Outstanding Shares | 69,527,315 |
Return
| Return on Equity | -90.32% |
|---|---|
| Return on Assets | -70.36% |
| Return on Invested Capital | -62.80% |
Valuation & Multiples
| P/E Ratio | -24.68 |
|---|---|
| PEG | -6.68 |
| Price to Sales | - |
| Price to Book Ratio | 21.62 |
| Enterprise Value to Revenue | 1769.87 |
| Enterprise Value to EBIT | -29.19 |
| Enterprise Value to Net Income | -24 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.07 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
June 1, 2026
EPS Estimate
$-0.92
Average shareholder expectationRevenue Estimate
$602,961
Average shareholder expectationNext Earnings Call
Expected Date
September 14, 2026
EPS Estimate
$-0.96
Average shareholder expectationRevenue Estimate
$778,451
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.1765▼ 42.13% |
|---|---|
| Total Calls | 1,700▼ 99.91% |
| Total Puts | 300▼ 99.97% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.11%▼ 71.86% |
|---|---|
| Total Invested | $10.05M▼ 99.82% |
| Investors Holding | 27▼ 259.00% |
ESG Score
No data